baber/WOPTO huggingface dataset:
Patent AU-2003287649-A1 (AU)
Title: Method and apparatus to perform translation in a modular system comprising network nodes and a switching fabric
Inventor: LEBIZAY GERALD
IPC: H04L29/06
Filed: 2003-11-12
Abstract: Techniques for performing protocol translation for a modular system may be described. In some examples, a first packet created in accordance with a first protocol may be received. A packet type for the first packet may be determined, a second protocol based on the packet type may be selected and the first packet may be translated to a second packet in accordance with the second protocol. Other embodiments are described and claimed.
Patent AU-2003288806-A1 (AU)
Title: Configurable diffractive optical element
Inventor: LOVHAUGEN ODD
IPC: G02B5/18
Filed: 2003-12-22
Abstract: This invention relates to a configurable diffractive optical element comprising an array of diffractive sub-elements having a reflective surface, wherein each sub-element has a controllable position with a chosen range, and in which a number of sub-elements are provided with a reflective grating with a number of chosen spectral characteristics.
Patent AU-2003304139-A1 (AU)
Title: Improved transfer set
Inventor: JANSEN HUBERT
IPC: A61J1/14
Filed: 2003-01-24
Abstract: A transfer set for transferring fluids from a first container, such as a conventional vial, to a second container, such as a conventional syringe. The transfer set includes an integral tubular housing having a tubular collar surrounding the rim of the vial, a radial portion sealingly engaging the stopper in the vial, an integral tubular transfer member and an outer tubular portion surrounding at least the distal portion of the tubular transfer member, a piercing member within the tubular transfer member and a closure releasably retaining the distal end of the piercing member.
Patent AU-2004251647-A1 (AU)
Title: Abuse resistant amphetamine compounds
Inventor: OBERLENDER ROB
IPC: A61K47/48
Filed: 2004-06-01
Abstract: The invention describes compounds, compositions, and methods of using the same comprising a chemical moiety covalently attached to amphetamine. These compounds and compositions are useful for reducing or preventing abuse and overdose of amphetamine. These compounds and compositions find particular use in providing an abuse-resistant alternative treatment for certain disorders, such as attention deficit hyperactivity disorder (ADHD), ADD, narcolepsy, and obesity. Oral bioavailability of amphetamine is maintained at therapeutically useful doses. At higher doses bioavailability is substantially reduced, thereby providing a method of reducing oral abuse liability. Further, compounds and compositions of the invention decrease the bioavailability of amphetamine by parenteral routes, such as intravenous or intranasal administration, further limiting their abuse liability.
Patent AU-2004263697-A1 (AU)
Title: Latch for joining two panels of an airplane structure
Inventor: VAUCHEL GUY
IPC: E05C19/14
Filed: 2004-06-30
Abstract: The lock has an operating unit (6) pivotally mounted around an end axle (13). An articulation has a pair of compression links (4) mounted pivotally around a main axle and an intermediate axle (14). A hook is inserted between the operating unit and the main axle. The link has a locking pin (21) contacting with a hook surface, situated in front of the operating unit, during the opening of the lock.
Patent AU-2004274483-A1 (AU)
Title: Polyether brevetoxin derivatives as a treatment for cystic fibrosis, mucociliary dysfunction, and pulmonary diseases
Inventor: BOURDELAIS ANDREA J
IPC: A61P11/12
Filed: 2004-09-20
Abstract: Disclosed are compounds that are derivatives of brevetoxin, or PbTx, pharmaceutical formulations comprising the compounds, and methods of regulating mucus transport in a cell, treating mucociliary dysfunction and diseases related to decreased mucus transport, wherein the compounds are of the Formula (I), and Formula (III): wherein R, R1, R2, R3, A, n, and Y are as defined herein for each compound.
Patent AU-2005211937-A1 (AU)
Title: Methods for treating resistant or refractory tumors
Inventor: CASAZZA ANNE MARIA
IPC: A61K33/243
Filed: 2005-02-18
Abstract: The instant invention relates to methods, pharmaceutical compositions and packaged pharmaceuticals for treating resistant or refractory tumors by administering platinum-based compounds.
Patent AU-2005304031-A1 (AU)
Title: Antibodies against tenascin-C
Inventor: SILACCI MICHELA
IPC: C12N15/13
Filed: 2005-10-31
Abstract: Specific binding members against extracellular matrix protein tenascin-C, especially scFv antibody molecules against domain A1, domain C and domain D of tenascin-C. Anti-tenascin-C specific binding members conjugated with labels, cytotoxic molecules or cytokines. Use of anti-tenascin-C specific binding members in diagnosis and treatment, especially of cancer.
Patent WO-2006079184-A1 (WO)
Title: Dispositif osseux intramedullaire ameliore
Inventor: GRIGGS IAN ROSS
IPC: A61B17/72
Filed: 2006-01-31
Abstract: La présente invention concerne un dispositif osseux intramédullaire comprenant un élément extérieur distal (10) ayant au moins une ouverture (20, 24) dans une paroi, un élément extérieur proximal (30) pour un positionnement dans un alignement sensiblement axial avec l’élément extérieur distal (10), l’élément extérieur proximal (30) ayant au moins une ouverture (44, 48) dans une paroi. L’élément extérieur distal (10) et l’élément extérieur proximal (30) ont chacun un passage. Le dispositif comprend aussi un élément intérieur distal (50) dont la taille est adaptée pour être reçu de manière coulissante dans le passage de l’élément extérieur distal (10) et un élément intérieur proximal (70) dont la taille est adaptée pour être reçu de manière coulissante dans le passage de l’élément extérieur proximal (30). Un allongeur/rétracteur (94) peut fonctionner de manière sélective pour modifier de manière sélective le positionnement longitudinal relatif entre l’élément intérieur distal (50) et l’élément intérieur proximal (70). L’allongeur/rétracteur (94) peut s’allonger ou se rétracter de manière sélective pour respectivement allonger ou raccourcir de manière sélective le dispositif. Le dispositif comprend des broches (102) pouvant se déplacer entre une position rétractée et une position allongée, les broches s’étendant à travers les ouvertures des éléments extérieurs distal et proximal pour fixer le dispositif à un os pendant l’utilisation.
Patent WO-2008074050-A1 (WO)
Title: Étiquette d'identification par radiofréquence capable d'offrir sécurité et confidentialité
Inventor: ATHERTON PETER SAMUEL
IPC: G06K19/077
Filed: 2006-12-18
Abstract: L'invention concerne une étiquette d'identification par radiofréquence (RFID) (100) pouvant être pliée autour d'une ligne de pliage généralement transversale (101). Cette ligne (101) divise l'étiquette (100) en deux régions (1 et 2). La région 1 comporte un circuit intégré RFID (104) et des zones (105) en matière électriquement conductrice. La région 2 comporte des zones conductrices (107) qui fournissent une antenne RFID efficace. En configuration pliée, les zones (107) sont fonctionnellement associées au circuit intégré (104), tandis qu'en configuration ouverte, ces zones (107) ne sont pas fonctionnellement associées au circuit intégré (104). En conséquence, en configuration ouverte, l'étiquette (100) est désactivée ou son efficacité d'identification par radiofréquence est sensiblement réduite. L'étiquette (100) peut passer d'une configuration ouverte à une configuration fermée ou inversement de manière réversible.
Patent AU-2006208719-A1 (AU)
Title: Method for optically transmitting polarisation multiplex signals
Inventor: HECKER NANCY
IPC: H04J14/02
Filed: 2006-01-25
Abstract: In order to reduce mutual interferences between POLMUX and signals, the signals are transmitted with differed to each other carrying signals, thereby making it possible to obtain the circular polarization of each resulting POLMUX signal. Each second POLMUX signal is transmissible with an opposite circular polarization. In order to reduce also interferences when only one modulated data signal is transmitted through a POLMUX channel, a polarization plane of modulated data signals of each second POLMUX channel is turned at 45°. In a variant, polarization multiplex signals are produces and the resulting polarizations thereof in adjacent channels are perpendicular to each other.
Patent AU-2006221214-A1 (AU)
Title: Refrigerant distributing device for multi-type air conditioner
Inventor: KIM CHAN GU
IPC: F25B39/02
Filed: 2006-03-07
Abstract: Disclosed herein is a refrigerant distributing device for a multi-type air conditioner, which can discharge an evenly mixed refrigerant to a plurality of indoor units. The refrigerant distributing device comprises an inlet pipe to supply a refrigerant, a distributor, and a plurality of outlet pipes. The distributor comprises an inlet port connected with the inlet pipe, a mix zone having a predetermined space formed therein such that the refrigerant induced through the inlet port forms a vortex flow within the mix zone so as to be evenly mixed, and a plurality of outlet ports separably connected with the mix zone to discharge the refrigerant having passed through the mix zone to an outside. The plurality of outlet pipes selectively connects at least one outlet ports of the distributor and each outlet pipe, for adjusting the amount of refrigerant supplied to each outlet pipe based on the capacity of each indoor unit connected with each outlet pipe.
Patent AU-2006239997-A1 (AU)
Title: Subsurface connection methods for subsurface heaters
Inventor: STEGEMEIER GEORGE LEO
IPC: H01R4/08
Filed: 2006-04-21
Abstract: A heating system for a subsurface formation is described. The heating system includes a first heater, a second heater, and a third heater placed in an opening in the subsurface formation. Each heater includes: an electrical conductor; an insulation layer at least partially surrounding the electrical conductor; and an electrically conductive sheath at least partially surrounding the insulation layer. The electrical conductor is electrically coupled to the sheath at a lower end portion of the heater. The lower end portion is the portion of the heater distal from a surface of the opening. The first heater, the second heater, and the third heater are electrically coupled at the lower end portions of the heaters. The first heater, the second heater, and the third heater are configured to be electrically coupled in a three-phase wye configuration.
Patent AU-2006241376-A1 (AU)
Title: Polymeric delivery formulations of leuprolide with improved efficacy
Inventor: RAVIVARAPU HARISH
IPC: A61K9/42
Filed: 2006-11-24
Abstract: The present invention is directed to a flowable composition that is suitable for use as a controlled release implant. The flowable composition includes a biodegradable thermoplastic polyester that is at least substantially insoluble in aqueous medium or body fluid. The flowable composition also includes a biocompatible polar aprotic solvent. The biocompatible polar aprotic solvent is miscible to dispersible in aqueous medium or body fluid. The flowable composition also includes leuprolide acetate. The present invention is also directed to a method for forming the flowable composition. The present invention is also directed to a biodegradable implant formed in situ, in a patient. The biodegradable implant is formed by injecting a flowable composition within the body of the patient and allowing the biocompatible polar aprotic solvent to dissipate to produce a solid biodegradable implant. The present invention is also directed to a method of forming a biodegradable implant in situ, in a living patient. The method includes injecting a flowable composition within the body of a patient and allowing the biocompatible polar aprotic solvent to dissipate to produce a solid biodegradable implant. The present invention is also directed to a method of treating cancer in a patient. The method includes administering to the patient in need of such treatment an effective amount of a flowable composition of the present invention. The present invention is also directed to a method of reducing LHRH levels in a patient. The method includes administering to the patient in need of such LHRH reduction an effective amount of a flowable composition of the present invention. The present invention is also directed to a kit. The kit includes a first container and a second container. The first container includes a composition that includes a biodegradable thermoplastic polyester and a biocompatible polar aprotic solvent. The second container includes leuprolide acetate. The present invention is also directed to a solid implant. The solid implant includes a biocompatible thermoplastic polyester and leuprolide acetate. The solid implant has a solid or gelatinous microporous matrix, wherein the matrix is a core surrounded by a skin. The solid implant can further include a biocompatible organic solvent.
Patent AU-2006259709-A1 (AU)
Title: Plastic conveyor belts and modules with lateral channels
Inventor: GUERNSEY KEVIN W
IPC: B65G17/00
Filed: 2006-06-02
Abstract: An easy-to-clean conveyor belt constructed of a series of rows of belt modules having lateral depressions forming channels across the width of the belt along which water can be sprayed to flush debris off the side edge of the belt. Lateral ridges between the depressions and hinge eyes at the ends of each module serve as levees that prevent debris being flushed through the channels from draining into hinge joints between consecutive belt rows.
Patent AU-2006275938-A1 (AU)
Title: Ophthalmic device lateral positioning system and associated methods
Inventor: BOWES JOHN J
IPC: A61F9/01
Filed: 2006-07-26
Abstract: A system and method for determining a lateral position of an eye relative to an ophthalmic device are disclosed. One embodiment of the method includes receiving data comprising an image of a surface of an eye. An edge feature in the image is located, wherein the edge feature is in a known relationship to a pupil of the eye. The image is mapped from the edge feature to laterally define the pupil, and a center of the pupil is determined using the pupil definition. The pupil center comprises a location from which to achieve a preferred lateral eye position relative to an ophthalmic device. An embodiment of the system of this invention can include a processor and a software package executable by the processor, the software package adapted to cause the processor to carry out the method steps.
Patent AU-2007231164-A1 (AU)
Title: Piperidines and related compounds for the treatment of dementia
Inventor: HARTMANN SASCHA
IPC: C07D211/34
Filed: 2007-03-27
Abstract: Compounds of formula I: modulate the action of gamma secretase, and hence find use in treatment of Alzheimer's disease and related conditions.
Patent WO-2009049355-A1 (WO)
Title: Module de base de mélangeur
Inventor: WILSON IAN GEOFFREY
IPC: B02C18/00
Filed: 2008-10-15
Abstract: L'invention concerne un module de base de mélangeur d'aliments ; ledit module étant conçu pour supporter un récipient de mélangeur et un ensemble de lames ; ledit module de base comportant un ensemble moteur d'entraînement, des circuits et des mécanismes de commande ; ledit module de base étant caractérisé en ce que le moteur de commande est au moins partiellement renfermé dans une enceinte de refroidissement, au moins une partie inférieure de ladite enceinte présentant un diamètre maximale plus petit qu'une longueur définie entre les extrémités extérieures de balais opposés dudit moteur d'entraînement. L'invention concerne également un procédé permettant de maximiser l'écoulement d'air de refroidissement autour et au travers d'un ensemble moteur dans un module de base de mélangeur d'aliments ; ledit procédé consistant à : (a) disposer les balais opposés d'un moteur d'entraînement de lame dudit assemblage à une extrémité de l'arbre de sortie dudit moteur d'entraînement, (b) placer un ventilateur au niveau d'une extrémité inférieure opposée dudit moteur d'entraînement, (c) prévoir une enceinte de refroidissement autour dudit moteur d'entraînement de lame, un diamètre intérieur maximale de ladite enceinte étant plus petit qu'une longueur définie par les extrémités extérieures desdits balais opposés.
Patent AU-2008214885-A1 (AU)
Title: A module for processing a fluid and a process for manufacture of same
Inventor: ZEILER MARTIN
IPC: B01D29/21
Filed: 2008-02-01
Abstract: The invention relates to a module for processing a fluid having a body of wound layers of a sheet material, the body having inner and outer surfaces, first and second end faces and a passage extending along the winding axis of said body in fluid communication with the inner surface, the sheet material having openings forming at least three types of channels, the channels extending from the inner surface to the outer surface, a first type of channel being open at the outer surface of the body and closed at the other end, a second type of channel being open at the inner surface of the body, in fluid communication with said passage and closed at the other end, a third type of channel being closed at both ends thereof and positioned such as to receive fluid from one or more channels of the first or second type.
Patent AU-2008255518-A1 (AU)
Title: Process for preparing the stable, amorphous calcium salt of (6S)-N(5)-methyl-5,6,7,8-tetrahydrofolic acid
Inventor: MOROSOLI MORENO
IPC: C07D475/04
Filed: 2008-05-29
Abstract: (6S)-N(5)-methyl-5,6,7,8-tetrahydrofolic acid calcium salt aqueous solution production involves methylating (6S)-5,6,7,8-tetrahydrofolic acid with a part of the corresponding (6R)-diastereoisomer in the range of 4-8 wt.% in water. Calcium chloride is added into the assigned quantity of tetrahydrofuran to obtain 0.70-0.82 equivalent of the methylated reaction mixture. The calcium salt of the (6RS)-N(5)-methyl-5,6,7,8-tetrahydrofolic acid is selectively crystallized and separated from the obtained aqueous solution. The obtained aqueous solution of the calcium salt of the (6S)-N(5)-methyl-5,6,7,8-tetrahydrofolic acid has less than or equal to 2.0 wt.% of the corresponding (6R)-diastereoisomer. Independent claims are included for: (1) a method for producing stable, crystalline (6S)-N(5)-methyl-5,6,7,8-tetrahydrofolic acid for use as an active component in a dietary supplement or in a medicine, for treating or suppression of human or animal tumors, and for synergistic influence of cancer suppressing compound, reducing toxicity of cancer suppressing compound, and protecting human or animal cells, which involves adding acetic acid or a sulfonic acid to an aqueous solution of the calcium salt of (6S)-N(5)-methyl-5,6,7,8-tetrahydrofolic acid with a portion of the corresponding (6R)-diastereoisomer of less than or equal to two weight percent; and (2) a method for producing stabilized, amorphous calcium salt of (6S)-N(5)-methyl-5,6,7,8-tetrahydrofolic acid, which involves suspending manufactured (6S)-N(5)-methyl-5,6,7,8-tetrahydrofolic acid in water, adding a solution of sodium hydroxide to this suspension, adding calcium chloride to the manufactured solution.
Patent AU-2009233653-A1 (AU)
Title: System and method for detection and removal of dental tartar
Inventor: AYOTTE FRANCOIS
IPC: A61C17/02
Filed: 2009-11-04
Abstract: A dental tartar detection and removal device (10) comprises a powered tartar removal instrument (12) adapted to be displaced along a tooth (T), illumination means (14) for illuminating with an incident light a region on the examined or periodontal site, detection means (16) for collecting the light reflected there at, and an analysing system for providing a signal to an operator (OP) of the tartar removal instrument (12) or to the tartar removal instrument when measurements on the reflected light in one or more predetermined ranges of wavelengths fall within any first predetermined range of values that are characteristic of tartar, or when said measurements do not fall within any second predetermined range of values that are characteristic of artefacts other than tartar. As a result of the signal, the removal instrument becomes actuated, either by the operator (OP) or automatically, and the operator can proceed to removing the detected tartar (S) without having to remove the detection device, whereby detection can be continued while the tartar removal instruments (12) is in a tartar removal position, and until all tartar (S) has been removed.
Patent AU-2009356489-A1 (AU)
Title: Sealing compounds with scavenger materials of small particle size
Inventor: COULTER WILLIAM DAVID
IPC: C08L23/04
Filed: 2009-12-08
Abstract: PVC-free polymer compound for producing seals containing scavengers for screw caps, in particular twist crown corks, characterized in that the Shore A hardness of the polymer compound lies between 50 and 90 and, in a compression set test analogous to ASTM D395-97, Method B, the polymer compound has a compression set of between 30% and 90% after it has been left for 22 hours at 70°C under a compression of 25%.
Patent WO-2011032212-A1 (WO)
Title: Chlorinateur d'eau salée
Inventor: DAVIDSON ROBERT BRUCE
IPC: C25B9/17
Filed: 2010-09-16
Abstract: La présente invention se rapporte à un chlorinateur d'eau salée (30) pour une piscine. Ledit chlorinateur d'eau salée comprend une cellule électrolytique ayant deux anodes (98) et une cathode (94). Deux racloirs (106), chacun d'entre eux étant en titane et comprenant des parties de raclage sous la forme de nervures (106) en contact avec les surfaces opposées de la cathode, ont un mouvement de va-et-vient par rapport à la cathode (94) pour retirer des dépôts de calcaire de la cathode (94). Les racloirs (102) sont montés sur un cadre (110) et leurs nervures de raclage (106) sont arrondies de telle sorte que les nervures (106) soient sollicitées automatiquement contre les surfaces de la cathode. Un mécanisme permettant un mouvement de va-et-vient des racloirs (102) comprend deux bobines de solénoïde (116) qui servent de parties centrales (114) dans une tige (112) du cadre (110). Un circuit de commande de la cellule électrolytique est contenu dans un boîtier (86) qui est fixé à un boîtier (82) de la cellule électrolytique. Le circuit de commande comprend un détecteur de flux pour détecter le flux d'eau salée à travers la cellule électrolytique.
Patent AU-2010206143-A1 (AU)
Title: PHD2 inhibition for blood vessel normalization, and uses thereof
Inventor: PETER CARMELIET
IPC: A61K33/243
Filed: 2010-01-20
Abstract: A key function of blood vessels, to supply oxygen, is impaired in tumors because of abnormalities in their endothelial lining. PHD proteins serve as oxygen sensors and may regulate oxygen delivery. Therefore the role of endothelial PHD2 in vessel shaping by implanting tumors in PHD2 mice was studied. Haplodeficiency of PHD2 did not affect tumor vessel density or lumen size, but normalized the endothelial lining and vessel maturation. This resulted in improved tumor perfusion and oxygenation, and inhibited tumor cell invasion, intravasation and metastasis. Haplodeficiency of PHD2 redirected the specification of endothelial tip cells to a more quiescent phenotype of a filopodia-lacking "phalanx" cell type. Without being bound to a particular mechanism, this transition could at least in part be explained by upregulation of (soluble) VEGFR-1 and VE-cadherin. Thus, decreased activity of an oxygen sensor in hypoxic conditions prompts endothelial cells to readjust their shape and phenotype to restore oxygen supply. I n hi biting P H D2 may offer alternative therapeutic opportunities for anti-cancer therapy, or other therapies where vascular normalization is beneficial.
Patent AU-2010212653-A1 (AU)
Title: Degradable perforation balls and associated methods of use in subterranean applications
Inventor: HONGYU LUO
IPC: E21B33/138
Filed: 2010-02-10
Abstract: Methods and compositions that include a method of treating a subterranean formation comprising the steps of providing a carrier fluid comprising degradable balls that comprise a carboxylic acid, a fatty alcohol, a fatty acid salt, a fatty ester, a fatty acid salt, or a combination thereof, and introducing the carrier fluid to the subterranean formation during a treatment.